文献速递血管炎

用于真实世界数据驱动的ANCA相关血管炎复发回顾性识别的可计算表型

Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis.
PubMed 文献 · RMD Open · 2024-04-30

本研究基于罕见肾病登记队列中536例ANCA相关血管炎患者,开发并内部验证了一种可计算表型,用于回顾性识别复发。该模型纳入5个数据元素,F1分数0.85、敏感度0.89、特异度0.96,可输出个体化复发概率。

要点

  • 可计算表型纳入5个关键数据元素:ANCA水平变化、提示性血/尿检查、提示性影像、免疫抑制状态、免疫抑制变化。
  • 模型F1分数0.85(95%CI 0.77-0.92),敏感度0.89(95%CI 0.80-0.99),特异度0.96(95%CI 0.93-0.99)。
  • 当免疫抑制变化缺失时,需提示性血/尿检查联合ANCA水平变化或提示性影像之一才能达到BVAS的准确性。

核心结论

  • 该可计算表型利用客观、易获取的登记数据,能准确回顾性量化ANCA相关血管炎患者的个体化复发概率。

研究设计与样本

  • 研究纳入罕见肾病登记(全国性纵向多中心队列研究)中536例ANCA相关血管炎且随访超过6个月的患者。
  • 研究分五步:独立 encounter 裁定、数据元素选择、多级回归建模开发可计算表型、内部验证、开发处理缺失值的额外模型。
  • 开发数据集和验证数据集分别包含1209和377次 encounter。

主要发现

  • 将诊断性组织病理学 encounter 分类为复发后,识别出5个关键数据元素:DE1 ANCA水平变化、DE2 提示性血/尿检查、DE3 提示性影像、DE4 免疫抑制状态、DE5 免疫抑制变化。
  • 模型F1分数0.85(95%CI 0.77-0.92),敏感度0.89(95%CI 0.80-0.99),特异度0.96(95%CI 0.93-0.99)。
  • 当DE5缺失时,需DE2联合DE1或DE3之一才能达到BVAS的准确性。

关键数值与推荐

  • 截断点通过最大化F1分数确定。
  • 开发了用于实施可计算表型的网络应用,输出个体化复发概率。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: ANCA-associated vasculitis (AAV) is a relapsing-remitting disease, resulting in incremental tissue injury. The gold-standard relapse definition (Birmingham Vasculitis Activity Score, BVAS>0) is often missing or inaccurate in registry settings, leading to errors in ascertainment of this key outcome. We sought to create a computable phenotype (CP) to automate retrospective identification of relapse using real-world data in the research setting. METHODS: We studied 536 patients with AAV and >6 months follow-up recruited to the Rare Kidney Disease registry (a national longitudinal, multicentre cohort study). We followed five steps: (1) independent encounter adjudication using primary medical records to assign the ground truth, (2) selection of data elements (DEs), (3) CP development using multilevel regression modelling, (4) internal validation and (5) development of additional models to handle missingness. Cut-points were determined by maximising the F1-score. We developed a web application for CP implementation, which outputs an individualised probability of relapse. RESULTS: Development and validation datasets comprised 1209 and 377 encounters, respectively. After classifying encounters with diagnostic histopathology as relapse, we identified five key DEs; DE1: change in ANCA level, DE2: suggestive blood/urine tests, DE3: suggestive imaging, DE4: immunosuppression status, DE5: immunosuppression change. F1-score, sensitivity and specificity were 0.85 (95% CI 0.77 to 0.92), 0.89 (95% CI 0.80 to 0.99) and 0.96 (95% CI 0.93 to 0.99), respectively. Where DE5 was missing, DE2 plus either DE1/DE3 were required to match the accuracy of BVAS. CONCLUSIONS: This CP accurately quantifies the individualised probability of relapse in AAV retrospectively, using objective, readily accessible registry data. This framework could be leveraged for other outcomes and relapsing diseases.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Scott J, White A, Walsh C, et al. Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis. RMD Open. 2024. PMID: 38688690. doi:10.1136/rmdopen-2023-003962

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。